FGFR3 and neoplasm: Indeed, the treatment of tumor‐bearing mice for 4 days with another pan‐FGFR inhibitor, BGJ398, which inhibited PDX tumor growth (Appendix Fig S6B), decreased both MYC and FGFR3 levels in the tumors (Fig 2F).